SLYG vs. RZG: Which Small-Cap Growth ETF Is the Better Buy for Investors?
2026-07-20 20:05
•Andy Gould •The Motley Fool
••••• •• Axe Capital view
SLYG vs. RZG: Which Small-Cap Growth ETF Makes More Sense?
Comparing two US-focused small-cap growth ETFs to find the better fit for South African investors.
Small-cap growth ETFs like SLYG and RZG offer US market exposure that can diversify a South African portfolio. SLYG stands out for lower fees (0.15% vs 0.35%) and a more diversified holding base (350 vs 126 stocks). That reduces risk and volatility, which is important when you’re also dealing with rand swings against the dollar. It also pays a small dividend—0.64%—helpful in a low-yield world where every bit of income counts. RZG’s recent 1-year return lead (34% vs 27%) is tempting, but it’s a trade-off with concentration risk, mostly in healthcare, and higher drawdowns. For South Africans, where USD/ZAR can amplify losses, I prefer the steadier, cost-efficient SLYG as a core US small-cap growth holding. This view might be wrong if RZG’s sectors outperform dramatically or volatility subsides, boosting its appeal. Still, in rand terms, cost and diversification usually win. this is just my opinion and not financial advice
I would buy SLYG for a core US small-cap growth allocation from South Africa, focusing on cost efficiency and risk management. Avoid RZG unless you have a high risk appetite for concentrated sectors.
- SLYG
- RZG
- USD/ZAR
- higher USD/ZAR volatility increasing dollar-exposure risk
- sector concentration in RZG leading to amplified losses with sector downturns
6/10
The article compares two small-cap growth ETFs: SLYG (State Street SPDR S&P 600 Small Cap Growth ETF) and RZG (Invesco S&P SmallCap 600 Revenue ETF). SLYG offers lower fees (0.15% vs 0.35%), broader diversification with 350 holdings, and higher dividend yield (0.64%), while RZG delivers stronger recent returns (34.14% vs 27.31% 1-year) but with higher volatility and concentration risk. Both funds show similar 5-year returns, making the choice dependent on investor priorities: cost and diversification favor SLYG, while momentum-seeking investors may prefer RZG.
This article was originally published by The Motley Fool and has been adapted here for Axe Capital Trading News.
Publisher: The Motley Fool
Author: Andy Gould
Categories: Rates, Equities, Earnings, Capital Returns, Healthcare
Tickers: SLYG, RZG
Sentiment: Positive - SLYG is presented as the better choice for cost-conscious, long-term investors due to its lower expense ratio (0.15%), broader diversification (350 holdings), higher dividend yield (0.64%), and lower maximum drawdown (29.17%), making it suitable as a core holding despite slightly lower recent returns. RZG is presented as a viable alternative with stronger recent 1-year returns (34.14%) and higher concentration in healthcare, but comes with drawbacks including higher fees (0.35%), greater volatility (38.33% max drawdown), and narrower portfolio (126 holdings), making it suitable only for momentum-seeking investors comfortable with higher risk.
Keywords: small-cap growth ETF, expense ratio, diversification, volatility, dividend yield, portfolio concentration
Insights:
- SLYG: Positive: SLYG is presented as the better choice for cost-conscious, long-term investors due to its lower expense ratio (0.15%), broader diversification (350 holdings), higher dividend yield (0.64%), and lower maximum drawdown (29.17%), making it suitable as a core holding despite slightly lower recent returns.
- RZG: Neutral: RZG is presented as a viable alternative with stronger recent 1-year returns (34.14%) and higher concentration in healthcare, but comes with drawbacks including higher fees (0.35%), greater volatility (38.33% max drawdown), and narrower portfolio (126 holdings), making it suitable only for momentum-seeking investors comfortable with higher risk.